Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF ...Middle East

PR Newswire - News
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF
GOTHENBURG, Sweden, May 4, 2021 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis (IPF), today announces the signing of an agreement with Alex...

Hence then, the article about vicore starts collaboration with alex therapeutics to develop new digital therapeutic for patients with ipf was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News